10-79557536-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001098668.4(SFTPA2):c.420C>T(p.Ser140Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 1,586,620 control chromosomes in the GnomAD database, including 68,001 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 7522 hom., cov: 30)
Exomes 𝑓: 0.28 ( 60479 hom. )
Consequence
SFTPA2
NM_001098668.4 synonymous
NM_001098668.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.123
Genes affected
SFTPA2 (HGNC:10799): (surfactant protein A2) This gene is one of several genes encoding pulmonary-surfactant associated proteins (SFTPA) located on chromosome 10. Mutations in this gene and a highly similar gene located nearby, which affect the highly conserved carbohydrate recognition domain, are associated with idiopathic pulmonary fibrosis. The current version of the assembly displays only a single centromeric SFTPA gene pair rather than the two gene pairs shown in the previous assembly which were thought to have resulted from a duplication. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 10-79557536-G-A is Benign according to our data. Variant chr10-79557536-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227069.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-79557536-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.123 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPA2 | NM_001098668.4 | c.420C>T | p.Ser140Ser | synonymous_variant | 6/6 | ENST00000372325.7 | NP_001092138.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPA2 | ENST00000372325.7 | c.420C>T | p.Ser140Ser | synonymous_variant | 6/6 | 1 | NM_001098668.4 | ENSP00000361400.2 | ||
SFTPA2 | ENST00000372327.9 | c.420C>T | p.Ser140Ser | synonymous_variant | 5/5 | 1 | ENSP00000361402.5 | |||
SFTPA2 | ENST00000417041.1 | c.420C>T | p.Ser140Ser | synonymous_variant | 6/6 | 5 | ENSP00000397375.1 |
Frequencies
GnomAD3 genomes AF: 0.308 AC: 46323AN: 150386Hom.: 7500 Cov.: 30
GnomAD3 genomes
AF:
AC:
46323
AN:
150386
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.280 AC: 65599AN: 234178Hom.: 11447 AF XY: 0.288 AC XY: 36496AN XY: 126786
GnomAD3 exomes
AF:
AC:
65599
AN:
234178
Hom.:
AF XY:
AC XY:
36496
AN XY:
126786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.280 AC: 401573AN: 1436114Hom.: 60479 Cov.: 36 AF XY: 0.283 AC XY: 202058AN XY: 713970
GnomAD4 exome
AF:
AC:
401573
AN:
1436114
Hom.:
Cov.:
36
AF XY:
AC XY:
202058
AN XY:
713970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.308 AC: 46396AN: 150506Hom.: 7522 Cov.: 30 AF XY: 0.309 AC XY: 22696AN XY: 73494
GnomAD4 genome
AF:
AC:
46396
AN:
150506
Hom.:
Cov.:
30
AF XY:
AC XY:
22696
AN XY:
73494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 12, 2015 | p.Ser140Ser in exon 6 of SFTPA2: This variant is not expected to have clinical s ignificance it has been identified in 45% (3704/8134) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1965707). - |
Interstitial lung disease 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at